{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:10:12Z","timestamp":1773864612804,"version":"3.50.1"},"reference-count":58,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,2,25]]},"DOI":"10.1253\/circj.cj-18-1293","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T22:28:48Z","timestamp":1546036128000},"page":"504-510","source":"Crossref","is-referenced-by-count":18,"title":["Controversies in the 2017 ACC\/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?\u3000\u2015 An Asian Perspective \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Sang-Hyun","family":"Ihm","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Bucheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bakris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Comprehensive Hypertension Center, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Hokko Memorial Clinic"},{"name":"Health Science University of Hokkaido"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Suk","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Kyung Hee University Hospital at Gangdong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Kon","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart Center, Gachon University Gil Medical Center"},{"name":"Gachon Cardiovascular Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2017; 71: e127\u2013e248.","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. <i>Eur Heart J<\/i> 2018; 39: 3021\u20133104.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, et al. Hypertension Canada\u2019s 2018 Guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. <i>Can J Cardiol<\/i> 2018; 34: 506\u2013525.","DOI":"10.1016\/j.cjca.2018.02.022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. American Diabetes Association. 9: Cardiovascular disease and risk management: Standards of medical care in diabetes \u2013 2018. <i>Diabetes Care<\/i> 2018; 41: S86\u2013S104.","DOI":"10.2337\/dc18-S009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. <i>Hypertension<\/i> 2003; 42: 1206\u20131252.","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part I: Epidemiology and diagnosis of hypertension. <i>Clin Hypertens<\/i> 2015; 21: 1.","DOI":"10.1186\/s40885-014-0012-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jee SH, Appel LJ, Suh I, Whelton PK, Kim IS. Prevalence of cardiovascular risk factors in South Korean adults: Results from the Korea Medical Insurance Corporation (KMIC) Study. <i>Ann Epidemiol<\/i> 1998; 8: 14\u201321.","DOI":"10.1016\/S1047-2797(97)00131-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kim SJ, Lee J, Nam CM, Jee SH, Park IS, Lee KJ, et al. Progression rate from new-onset pre-hypertension to hypertension in Korean adults. <i>Circ J<\/i> 2011; 75: 135\u2013140.","DOI":"10.1253\/circj.CJ-09-0948"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). <i>J Hypertens<\/i> 2013; 31: 1281\u20131357.","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2014). <i>Hypertens Res<\/i> 2014; 37: 253\u2013390.","DOI":"10.1038\/hr.2014.20"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB Sr, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2014; 63: 2935\u20132959.","DOI":"10.1016\/j.jacc.2013.11.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in chinese population: The China-PAR Project (Prediction for ASCVD Risk in China). <i>Circulation<\/i> 2016; 134: 1430\u20131440.","DOI":"10.1161\/CIRCULATIONAHA.116.022367"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kaasenbrood L, Boekholdt SM, van der Graaf Y, Ray KK, Peters RJ, Kastelein JJ, et al. Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population. <i>Circulation<\/i> 2016; 134: 1419\u20131429.","DOI":"10.1161\/CIRCULATIONAHA.116.021314"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2014; 63: 2889\u20132934.","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. <i>N Engl J Med<\/i> 2015; 373: 2103\u20132116.","DOI":"10.1056\/NEJMoa1511939"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2018; 71: 2176\u20132198.","DOI":"10.1016\/j.jacc.2017.11.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. <i>N Engl J Med<\/i> 2010; 362: 1575\u20131585.","DOI":"10.1056\/NEJMoa1001286"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. <i>Lancet<\/i> 2013; 382: 507\u2013515.","DOI":"10.1016\/S0140-6736(13)60852-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis. <i>Lancet<\/i> 2016; 387: 435\u2013443.","DOI":"10.1016\/S0140-6736(15)00805-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Myers MG, Campbell NR. Unfounded concerns about the use of automated office blood pressure measurement in SPRINT. <i>J Am Soc Hypertens<\/i> 2016; 10: 903\u2013905.","DOI":"10.1016\/j.jash.2016.10.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, et al. Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey). <i>Circulation<\/i> 2017; 135: 1617\u20131628.","DOI":"10.1161\/CIRCULATIONAHA.116.025322"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Phillips RA, Xu J, Peterson LE, Arnold RM, Diamond JA, Schussheim AE. Impact of cardiovascular risk on the relative benefit and harm of intensive treatment of hypertension. <i>J Am Coll Cardiol<\/i> 2018; 71: 1601\u20131610.","DOI":"10.1016\/j.jacc.2018.01.074"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. de Boer IH, Bakris G, Cannon CP. Individualizing blood pressure targets for people with diabetes and hypertension: Comparing the ADA and the ACC\/AHA recommendations. <i>JAMA<\/i> 2018; 319: 1319\u20131320.","DOI":"10.1001\/jama.2018.0642"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Buckley LF, Dixon DL, Wohlford GF, Wijesinghe DS, Baker WL, Van Tassell BW. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants. <i>Diabetes Obes Metab<\/i> 2018; 20: 1499\u20131502.","DOI":"10.1111\/dom.13248"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lonn EM, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. <i>N Engl J Med<\/i> 2016; 374: 2009\u20132020.","DOI":"10.1056\/NEJMoa1600175"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cho KI, Sakuma I, Sohn IS, Hayashi T, Shimada K, Koh KK. Best treatment strategies with statins to maximize the cardiometabolic benefits. <i>Circ J<\/i> 2018; 82: 937\u2013943.","DOI":"10.1253\/circj.CJ-17-1445"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ. Combining potent statin therapy with other drugs to optimize simultaneous cardiovascular and metabolic benefits while minimizing adverse events. <i>Korean Circ J<\/i> 2017; 47: 432\u2013439.","DOI":"10.4070\/kcj.2016.0406"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels \u2013 overview and meta-analyses of randomized trials. <i>J Hypertens<\/i> 2014; 32: 2296\u20132304.","DOI":"10.1097\/HJH.0000000000000379"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs. Standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: A randomized clinical trial. <i>JAMA<\/i> 2016; 315: 2673\u20132682.","DOI":"10.1001\/jama.2016.7050"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. <i>J Am Coll Cardiol<\/i> 2017; 69: 486\u2013493.","DOI":"10.1016\/j.jacc.2016.10.077"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: An international cohort study. <i>Lancet<\/i> 2016; 388: 2142\u20132152.","DOI":"10.1016\/S0140-6736(16)31326-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kimm H, Mok Y, Lee SJ, Lee S, Back JH, Jee SH. The J-curve between diastolic blood pressure and risk of all-cause and cardiovascular death. <i>Korean Circ J<\/i> 2018; 48: 36\u201347.","DOI":"10.4070\/kcj.2017.0036"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. <i>Arch Intern Med<\/i> 1999; 159: 2004\u20132009.","DOI":"10.1001\/archinte.159.17.2004"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lee SE, Lee HY, Cho HJ, Choe WS, Kim H, Choi JO, et al. Reverse J-curve relationship between on-treatment blood pressure and mortality in patients with heart failure. <i>JACC Heart Fail<\/i> 2017; 5: 810\u2013819.","DOI":"10.1016\/j.jchf.2017.08.015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sandesara PB, O\u2019Neal WT, Kelli HM, Topel M, Samman-Tahhan A, Sperling LS. Diastolic blood pressure and adverse outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial. <i>J Am Heart Assoc<\/i> 2018; 7: e007475.","DOI":"10.1161\/JAHA.117.007475"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kitamura A, Yamagishi K, Imano H, Kiyama M, Cui R, Ohira T, et al. Impact of hypertension and subclinical organ damage on the incidence of cardiovascular disease among Japanese residents at the population and individual levels: The Circulatory Risk in Communities Study (CIRCS). <i>Circ J<\/i> 2017; 81: 1022\u20131028.","DOI":"10.1253\/circj.CJ-16-1129"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kario K, Bhatt DL, Brar S, Bakris GL. Differences in dynamic diurnal blood pressure variability between Japanese and American treatment-resistant hypertensive populations. <i>Circ J<\/i> 2017; 81: 1337\u20131345.","DOI":"10.1253\/circj.CJ-16-1237"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S. The burden of blood pressure-related disease: A neglected priority for global health. <i>Hypertension<\/i> 2007; 50: 991\u2013997.","DOI":"10.1161\/HYPERTENSIONAHA.107.095497"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Huh JH, Kang DR, Jang JY, Shin JH, Kim JY, Choi S, et al. Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018). <i>Atherosclerosis<\/i> 2018; 277: 47\u201352.","DOI":"10.1016\/j.atherosclerosis.2018.08.003"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Body-mass index and mortality in Korean men and women. <i>N Engl J Med<\/i> 2006; 355: 779\u2013787.","DOI":"10.1056\/NEJMoa054017"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nakano M, Eguchi K, Sato T, Onoguchi A, Hoshide S, Kario K. Effect of intensive salt-restriction education on clinic, home, and ambulatory blood pressure levels in treated hypertensive patients during a 3-month education period. <i>J Clin Hypertens (Greenwich)<\/i> 2016; 18: 385\u2013392.","DOI":"10.1111\/jch.12770"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Hoshide S, Cheng HM, Huang Q, Park S, Park CG, Chen CH, et al. Role of ambulatory blood pressure monitoring for the management of hypertension in Asian populations. <i>J Clin Hypertens (Greenwich)<\/i> 2017; 19: 1240\u20131245.","DOI":"10.1111\/jch.13086"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, et al. Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: Findings from the CSPPT (China Stroke Primary Prevention Trial). <i>Hypertension<\/i> 2017; 69: 697\u2013704.","DOI":"10.1161\/HYPERTENSIONAHA.116.08499"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 7: Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels \u2013 updated overview and meta-analyses of randomized trials. <i>J Hypertens<\/i> 2016; 34: 613\u2013622.","DOI":"10.1097\/HJH.0000000000000881"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Lee CJ, Hwang J, Lee YH, Oh J, Lee SH, Kang SM, et al. Blood pressure level associated with lowest cardiovascular event in hypertensive diabetic patients. <i>J Hypertens<\/i> 2018; 36: 2434\u20132443.","DOI":"10.1097\/HJH.0000000000001842"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Seo J, Lee CJ, Hwang J, Oh J, Lee SH, Kang SM, et al. Optimal blood pressure in elderly hypertensive subjects: A Korean National Health Insurance Service Health Examinee cohort study. <i>Am J Hypertens<\/i> 2018; 31: 1033\u20131041.","DOI":"10.1093\/ajh\/hpy081"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Guo X, Liu Y, Yang N, Liu P, Zhu Y, Xia X, et al. Association of systolic blood pressure with cardiovascular outcomes in elderly patients with hypertension in Northern China. <i>Blood Press Monit<\/i> 2018; 23: 271\u2013276.","DOI":"10.1097\/MBP.0000000000000339"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study. <i>Hypertension<\/i> 2010; 56: 196\u2013202.","DOI":"10.1161\/HYPERTENSIONAHA.109.146035"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Rakugi H, Ogihara T, Goto Y, Ishii M, Group JS. Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: A per-protocol analysis of JATOS. <i>Hypertens Res<\/i> 2010; 33: 1124\u20131128.","DOI":"10.1038\/hr.2010.144"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Lee CJ, Hwang J, Oh J, Lee SH, Kang SM, Kim HC, et al. Relation between blood pressure and clinical outcome in hypertensive subjects with previous stroke. <i>J Am Heart Assoc<\/i> 2017; 6: e007102.","DOI":"10.1161\/JAHA.117.007102"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. <i>Lancet<\/i> 2002; 360: 1903\u20131913.","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Liu K, Colangelo LA, Daviglus ML, Goff DC, Pletcher M, Schreiner PJ, et al. Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels? The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA). <i>J Am Heart Assoc<\/i> 2015; 4: e002275.","DOI":"10.1161\/JAHA.115.002275"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Son JS, Choi S, Kim K, Kim SM, Choi D, Lee G, et al. Association of blood pressure classification in Korean young adults according to the 2017 American College of Cardiology\/American Heart Association Guidelines with subsequent cardiovascular disease events. <i>JAMA<\/i> 2018; 320: 1783\u20131792.","DOI":"10.1001\/jama.2018.16501"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Wan EYF, Yu EYT, Chin WY, Fung CSC, Fong DYT, Choi EPH, et al. Effect of achieved systolic blood pressure on cardiovascular outcomes in patients with type 2 diabetes: A population-based retrospective cohort study. <i>Diabetes Care<\/i> 2018; 41: 1134\u20131141.","DOI":"10.2337\/dc17-2443"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Bakris G, Sorrentino M. Perspective on the new blood-pressure guidelines. <i>Eur Heart J<\/i> 2018; 39: 3008\u20133009.","DOI":"10.1093\/eurheartj\/ehy280"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Messerli FH, Bangalore S. Should we SPRINT toward new blood pressure goals or let the dust settle? <i>Am J Med<\/i> 2016; 129: 769\u2013770.","DOI":"10.1016\/j.amjmed.2016.04.022"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Akinseye OA, Williams SK, Seixas A, Pandi-Perumal SR, Vallon J, Zizi F, et al. Sleep as a mediator in the pathway linking environmental factors to hypertension: A review of the literature. <i>Int J Hypertens<\/i> 2015; 2015: 926414.","DOI":"10.1155\/2015\/926414"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Tamisier R, Weiss JW, Pepin JL. Sleep biology updates: Hemodynamic and autonomic control in sleep disorders. <i>Metabolism<\/i> 2018; 84: 3\u201310.","DOI":"10.1016\/j.metabol.2018.03.012"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/3\/83_CJ-18-1293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T04:40:03Z","timestamp":1551501603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/3\/83_CJ-18-1293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-1293","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]}}}